Effectiveness, safety and potential predictors of response at week 16 in patients with severe hidradenitis suppurativa treated with secukinumab: A multicenter observational retrospective study

被引：0
|
作者：
Serrano, Pablo Fernandez-Crehuet [3 ,4 ]
Haselgruber-deFrancisco, Sofia [1 ]
Padial-Gomez, Alicia [5 ]
Vasquez-Chinchay, Fiorella [6 ]
Fernandez-Ballesteros, Maria D. [7 ]
Lopez-Riquelme, Irene [7 ]
Jimenez-Gallo, David [8 ]
Segura-Palacios, Juan M. [9 ]
Contreras-Steyls, Marisol [10 ]
Osorio-Gomez, Guiovana F. [11 ]
Hernandez-Rodriguez, Juan Carlos [11 ]
Cuenca-Barrales, Carlos [1 ]
Molina-Leyva, Alejandro [1 ,2 ]
机构：
[1] Hosp Univ Virgen de las Nieves, IBS Granada, Hidradenitis Suppurativa Clin, Granada, Spain
[2] European Hidradenitis Suppurativa Fdn, Dessau Rosslau, Germany
[3] Hosp Reina Sofia Cordoba, Cordoba, Spain
[4] IMIBIC, Dept Dermatol, Cordoba, Spain
[5] Hosp Univ Jerez de la Frontera, Dept Dermatol, Jerez de la Frontera, Spain
[6] Hosp Univ Virgen Valme, Dept Dermatol, Seville, Spain
[7] Hosp Univ Reg Malaga, Dept Dermatol, Malaga, Spain
[8] Hosp Univ Puerta Mar, Dept Dermatol, Cadiz, Spain
[9] Hosp Costa Sol, Dept Dermatol, Marbella, Spain
[10] Hosp Univ Virgen de la Victoria, Dept Dermatol, Malaga, Spain
[11] Hosp Univ Virgen de Rocio, Dept Dermatol, Seville, Spain
来源：
EXPERIMENTAL DERMATOLOGY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：108 / 108
页数：1
相关论文
共 50 条
  • [31] Long-term secukinumab efficacy in patients with moderate to severe hidradenitis suppurativa: A retrospective single-centre case series (23 patients)
    Ramos, Francisco Javier Melgosa
    Ruiz, Ramon Garcia
    Corrales, Andrea Estebanez
    Puchades, Almudena Mateu
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (04) : E517 - E519
  • [32] Infliximab treatment before and after surgery in severe hidradenitis suppurativa: A retrospective study of 10 patients
    Benassia, E. .
    Boccara, D.
    Mimoun, M.
    Chaouat, M.
    Hotz, C.
    Bachelez, H.
    Bouaziz, J-D.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2022, 149 (03): : 195 - 197
  • [33] Efficacy and safety of secukinumab in patients with moderate-to-severe hidradenitis suppurativa: Final results from the Phase 3 SUNSHINE and SUNRISE trials
    Kimball, Alexa B.
    Jemec, Gregor B. E.
    Alavi, Afsaneh
    Reguiai, Ziad
    Gottlieb, Alice
    Wozniak, Magdalena B.
    Uhlmann, Lorenz
    Martinez, Angela Llobet
    Field, Claire
    Ravichandran, Shoba
    Muscianisi, Elisa
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB156 - AB156
  • [34] Ertapenem for the treatment of hidradenitis suppurativa: A multicenter retrospective study. Description of candidate patients and administration route
    Segura Palacios, Juan Manuel
    Soto Moreno, Alberto
    V-Millan, Ismael
    Rivas Ruiz, Francisco
    Cuenca Barrales, Carlos
    Molina Leyva, Alejandro
    EXPERIMENTAL DERMATOLOGY, 2023, 32 : 116 - 117
  • [35] Real-World Effectiveness and Safety of Risankizumab in Adult Patients with Plaque Psoriasis: A 16-Week International Multicenter Retrospective Cohort Study
    Bagit, Ahmed
    Maliyar, Khalad
    Mansour, Mark
    Georgakopoulos, Jorge R.
    Rankin, Brian D.
    Lytvyn, Yuliya
    Zaaroura, Hiba
    Park, Ye-Jean
    Wang, Ou Jia
    Mufti, Asfandyar
    Torres, Tiago
    Le, Ana M.
    Vender, Ronald
    Prajapati, Vimal H.
    Yeung, Jensen
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2024, 28 (06) : 604 - 605
  • [36] Evaluating the safety and effectiveness of secukinumab dose optimization in adult psoriasis patients: A retrospective multicenter case series
    Phung, Michelle
    Georgakopoulos, Jorge R.
    Ighani, Arvin
    Giroux, Lyne
    Yeung, Jensen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB135 - AB135
  • [37] Drug survival, discontinuation rates, and safety profile of secukinumab in real-world patients: a 152-week, multicenter, retrospective study
    Ruiz-Villaverde, Ricardo
    Rodriguez-Fernandez-Freire, Lourdes
    Galan-Gutierrez, Manuel
    Armario-Hita, Jose C.
    Martinez-Pilar, Leandro
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (05) : 633 - 639
  • [38] Anti-IL-17/23 Drugs for the Treatment of Moderate-to-Severe Hidradenitis Suppurativa in Patients With Concomitant Psoriasis: A Multicenter Retrospective Study
    Gargiulo, Luigi
    Ibba, Luciano
    Narcisi, Alessandra
    Giordano, Silvia
    Maronese, Carlo A.
    Martora, Fabrizio
    Repetto, Federica
    Paolino, Giovanni
    Balato, Anna
    Burlando, Martina
    Dapavo, Paolo
    Dini, Valentina
    Guarneri, Claudio
    Marzano, Angelo V.
    Megna, Matteo
    Mercuri, Santo R.
    Costanzo, Antonio
    Valenti, Mario
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2024, 14 (04):
  • [39] Secukinumab Demonstrated High Effectiveness in Vietnamese Patients with Moderate-To-Severe Plaque Psoriasis in a Real-World Clinical Setting: 16 Week Results from an Observational Study
    Hao T. Nguyen
    Nhi T. U. Pham
    Tu N. A. Tran
    Nhuong T. T. Nguyen
    Thao T. P. Vu
    Dermatology and Therapy, 2021, 11 : 1613 - 1621
  • [40] The Effectiveness of Guselkumab in Patients With Hidradenitis Suppurativa Under Clinical Practice Conditions: A Spanish Multicentre Retrospective Study
    Rivera-Diaz, R.
    Pozo, T.
    Alfageme, F.
    Ley, B. Diaz
    Osorio, G. F.
    Chico, R.
    Vilarrasa, E.
    Silvente, C.
    Blanco, C. Ciudad
    Romani, J.
    Martorell, A.
    Fernandez, P.
    Ferreiro, C. Romero
    Leyva, A. Molina
    ACTAS DERMO-SIFILIOGRAFICAS, 2023, 114 (09): : T755 - T762
12345